Pill Swallow Study

RANI Therapeutics150 enrolled

Overview

A prospective, single-center, open-label, single-arm, observational study assessing participant experience with swallowing the Mock-RP

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

150

Conditions

Not Determined

Interventions

Mock-RPOTHER

Standard 000 capsule filled with potato starch, enteric-coated with colorant and lubricious coating.

Eligibility

Sex: ALLMin age: 21 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Participant age is 21 - 75 years 2. Participant understands the nature of the study, is willing to comply with protocol defined evaluations, and provide written informed consent 3. Participant currently taking injections to treat a chronic disorder 4. Non-pregnant, non-lactating female NOTE: Females who are of childbearing potential must have had a negative pregnancy test on day of screening Exclusion Criteria: 1. Active case of COVID-19 2. History of Dysphagia 3. History of dementia (e.g., Alzheimer's, vascular dementia, dementia with Lewy bodies, etc.) 4. Participant self-reports issues with swallowing pills. 5. History of drug or alcohol abuse or any other factor that, in the Investigator's opinion, may interfere with the participant's ability to cooperate and comply with the study procedures 6. History of allergic reaction to a component of the Mock-RP 7. History which, in the investigator's judgement, makes the participant ineligible or exposes the participant to unacceptable risks

Locations (1)

Clinical Trials of Texas

San Antonio, Texas, United States